Clinical trials are being reevaluated with the use of synthetic control arms, which may expedite clinical research. This approach is being considered for various applications, including rare tumors and lung diseases. The potential of synthetic control arms to improve clinical trial design and delivery is being explored, with some studies already validating their effectiveness.